-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Orthopoxvirus
- Others
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Virus Protease
- Antiviral intermediates
Encephalitic-alphavirus-IN-1
![{PARAM:[Name]}()](https://resource.bocsci.com/structure/encephalitic-alphavirus-in-1.gif)
| Category | Virus Protease |
| Description | Encephalitic alphavirus-IN-1 has antiviral activity for VEEV and EEEV with EC50s of 0.24 μM and 0.16 μM, respectively. |
Product Information
| Synonyms | Encephalitic alphavirus-IN-1|HY-145842|CS-0434183 |
| Molecular Weight | 484.52 |
| Molecular Formula | C27H25FN6O2 |
| Canonical SMILES | CC1=NC=C(C=C1)C2=C3C(=CC(=C2)C#N)C(=O)N(C4C(=N3)N(CCN4C)C)C5=CC(=C(C=C5)OC)F |
| Purity | ≥98% (HPLC) |
| Density | 1.2±0.1 g/cm3 |
| Solubility | In vitro: 10 mM in DMSO |
| Appearance | Solid powder |
| Storage | Store at -20°C |
| Complexity | 906 |
| Exact Mass | 484.20230222 |
| Index Of Refraction | 1.637 |
| In Vitro | Encephalitic alphavirus-IN-1 (1 and 5 μM; 18 hours) reduces substantial VEEV and EEEV in human brain primary neuronal cells. |
| Target | EC50: 0.24 μM (VEEV), 0.16 μM (EEEV) |
| XLogP3-AA | 2.9 |
